Meningococcal infection is a severe disease that may grow potentially fatal within just a few hours. The bacteria Neisseria meningitidis, also referred to as meningococcus, usually causes purulent meningitis, and, more rarely, blood poisoning (sepsis). In Germany, meningococcal disease is rare, with around 4 cases per 1 million people per year. Generally, these involve isolated cases or local outbreaks – especially in the winter months.
Person-to-person
Meningococci are most commonly transmitted as an airborne infection. The bacteria congregate in the human nasopharyngeal cavity. During speaking, coughing or sneezing, they are released into the air in small droplets from the throat and nasal cavity and can be breathed in over short distances.
The pathogens can also be transmitted by intimate contact with someone suffering from the disease – by touching nasal secretions, for example. Outside the body, however, bacteria die off quickly.
The disease onset is typically very sudden and progresses rapidly. With babies and infants, the symptoms of meningococcal disease may be less clear-cut.
Meningococcal disease can progress in one of two ways, or both may occur simultaneously:
Fever, headache, sensitivity to light and a state of “foggy-headedness” – such as feeling very sleepy or woozy – are the usual symptoms for meningococcal inflammation of the membranes of the brain (i.e. meningitis). One typical symptom is painful stiffness in the nape of the neck, often combined with morning sickness or symptoms of cardiovascular failure and occasional seizures. Patients usually feel very ill. In severe cases, blood clotting disorders produce spots or areas of haemorrhaging over the skin and mucous membranes.
Around 10–20% of all patients will ultimately suffer complications such as seizures or deafness, while children may also suffer developmental disorders. The illness is fatal in about 1% of cases.
With meningococcal sepsis, the bacteria enter the bloodstream and flood the patient’s entire body. Blood coagulation is also disrupted. This will lead to large-scale bleeding in the skin. For 10–15% of patients, this life-threatening haemorrhaging may also occur in the cortex of the adrenal glands, which can result in circulatory shock. In some cases, complications may include gangrene in individual limbs, which in the worst case may then require amputation. Almost 1 in 10 patients will die from this sepsis; in serious cases, the figure is more like 1 in 3.
For babies and infants, symptoms such as fever, vomiting, cramps, irritability or sleepiness may also be accompanied by a protruding or hard fontanelle – the gap between the skull plates in infants. The stiff neck, in contrast, may be missing.
As a rule, the first signs of illness appear 2 to 10 days after infection, typically within 3 to 4 days. Patients are infectious for up to 7 days before the appearance of symptoms. Twenty-four hours after beginning an effective course of antibiotics, patients are no longer infectious.
Anyone can contract meningococcal disease. Most commonly, however, the disease affects babies in their first year of life, infants or young people. There is a greater risk of infection under poor hygienic conditions, with a weakened immune system or in cramped living quarters. Smoking or a previous viral infection of the airways can also increase a person’s sensitivity to meningococcal disease.
Vaccination
There are different types of meningococci. Serogroups B and C are most frequent in Germany. The German Permanent Vaccination Commission (STIKO) recommends vaccination against serogroup C for all children aged between 12 and 23 months. Individuals not vaccinated as a child should receive a vaccination before the age of 18. Immunisation against other serogroups (ACWY and/or B) is also available and is also recommended for certain high-risk groups:
Talk to your GP about the necessity for a vaccination, as well as the risks and benefits of immunisation.
As a person with patient contact
Your local health authority can provide you with further advice. Since meningococcal infections must be reported, theywill also have the latest information and be very experienced in dealing with the disease.
More (specialist) information is also available online from the Robert Koch Institute (www.rki.de/meningokokken).
For information about how vaccinations stop infection, visit the website set up by the Federal Centre for Health Education (www.impfen-info.de).